Committee on Science, Space, & Technology, Subcommittee on Investigations & Oversight and Committee on Small Business, Subcommittee on Healthcare & Technology – Joint Hearing

Subcommittee on Investigations and Oversight | 2318 Rayburn House Office Building Washington, DC 20515 | Apr 25, 2012 10:00am

How the Report on Carcinogens Uses Science to Meet its Statutory Obligations, and its Impact on Small Business Jobs

Hearing Charter

Opening Statements

I&O Subcommittee Chairman Paul Broun (R-GA)

H&T Subcommittee Chairwoman Renee Ellmers (R-NC)

Witnesses

Panel I

Dr. Linda S. Birnbaum, Director, National Institute of Environmental Health Sciences & National Toxicology Program, U.S. Department of Health and Human Services
Truth in Testimony

Mr. Charles A. Maresca, Director of Interagency Affairs, Office of Advocacy, U.S. Small Business Administration
Truth in Testimony

Panel II

Dr. James S. Bus, Director of External Technology, Toxicology and Environmental Research and Consulting, The Dow Chemical Company
Truth in Testimony

Dr. L. Faye Grimsley, Associate Professor, Tulane School of Public Health and Tropical Medicine, Department of Global Environmental Health Sciences
Truth in Testimony

Ms. Bonnie Webster, Vice President, Monroe Industries, Inc.
Truth in Testimony

Ms. Ally LaTourelle, Esq., Vice President, Government Affairs, Bioamber, Inc
Truth in Testimony

Mr. John E. Barker, Corporate Manager, Environmental Affairs, Safety and Loss Prevention, Strongwell Corporation
Truth in Testimony

Dr. Richard B. Belzer, President, Regulatory Checkbook
Truth in Testimony